Correlation Between Black Diamond and Sana Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Black Diamond and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Black Diamond Therapeutics and Sana Biotechnology, you can compare the effects of market volatilities on Black Diamond and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Sana Biotechnology.

Diversification Opportunities for Black Diamond and Sana Biotechnology

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Black and Sana is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of Black Diamond i.e., Black Diamond and Sana Biotechnology go up and down completely randomly.

Pair Corralation between Black Diamond and Sana Biotechnology

Given the investment horizon of 90 days Black Diamond Therapeutics is expected to generate 1.13 times more return on investment than Sana Biotechnology. However, Black Diamond is 1.13 times more volatile than Sana Biotechnology. It trades about -0.07 of its potential returns per unit of risk. Sana Biotechnology is currently generating about -0.17 per unit of risk. If you would invest  476.00  in Black Diamond Therapeutics on August 28, 2024 and sell it today you would lose (225.00) from holding Black Diamond Therapeutics or give up 47.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Black Diamond Therapeutics  vs.  Sana Biotechnology

 Performance 
       Timeline  
Black Diamond Therap 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Black Diamond Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Sana Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sana Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Black Diamond and Sana Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Black Diamond and Sana Biotechnology

The main advantage of trading using opposite Black Diamond and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.
The idea behind Black Diamond Therapeutics and Sana Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format